Literature DB >> 15764194

Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole.

Olaf Burkhardt1, Thomas Köhnlein, Mathias Pletz, Tobias Welte.   

Abstract

Saccharomyces boulardii is frequently used for prevention and treatment of all forms of diarrhoea. We report the case of a 19-y-old white male with an underlying severe neurological disease, who developed a fungal sepsis after prophylactic application of a drug containing S. boulardii. Initial treatment with fluconazole was not successful. After the application of voriconazole, the sepsis resolved completely. This is the first clinical report of a successful treatment of Saccharomyces sepsis with voriconazole.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15764194     DOI: 10.1080/00365540510026454

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  11 in total

Review 1.  Risk and safety of probiotics.

Authors:  Shira Doron; David R Snydman
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

2.  Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study.

Authors:  Makbule Eren; Ener C Dinleyici; Yvan Vandenplas
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

3.  Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora.

Authors:  Ipek Akil; Ozge Yilmaz; Semra Kurutepe; Kenan Degerli; Salih Kavukcu
Journal:  Pediatr Nephrol       Date:  2006-04-20       Impact factor: 3.714

Review 4.  Saccharomyces boulardii in childhood.

Authors:  Yvan Vandenplas; Oscar Brunser; Hania Szajewska
Journal:  Eur J Pediatr       Date:  2008-12-19       Impact factor: 3.183

5.  Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.

Authors:  Theodoros Kelesidis; Charalabos Pothoulakis
Journal:  Therap Adv Gastroenterol       Date:  2012-03       Impact factor: 4.802

6.  Probiotic Survey in Cancer Patients Treated in the Outpatient Department in a Comprehensive Cancer Center.

Authors:  Sona Ciernikova; Michal Mego; Maria Semanova; Lenka Wachsmannova; Zuzana Adamcikova; Viola Stevurkova; Lubos Drgona; Vladimir Zajac
Journal:  Integr Cancer Ther       Date:  2016-05-05       Impact factor: 3.279

7.  Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients.

Authors:  Beata Sulik-Tyszka; Emilian Snarski; Magda Niedźwiedzka; Małgorzata Augustyniak; Thorvald Nilsen Myhre; Anna Kacprzyk; Ewa Swoboda-Kopeć; Marta Roszkowska; Jadwiga Dwilewicz-Trojaczek; Wiesław Wiktor Jędrzejczak; Marta Wróblewska
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

Review 8.  Anti-tumor activities of probiotics in cervical cancer.

Authors:  Moghaddaseh Jahanshahi; Parisa Maleki Dana; Bita Badehnoosh; Zatollah Asemi; Jamal Hallajzadeh; Mohammad Ali Mansournia; Bahman Yousefi; Bahram Moazzami; Shahla Chaichian
Journal:  J Ovarian Res       Date:  2020-06-11       Impact factor: 4.234

Review 9.  Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis.

Authors:  Karolina Kaźmierczak-Siedlecka; Aleš Dvořák; Marcin Folwarski; Agnieszka Daca; Katarzyna Przewłócka; Wojciech Makarewicz
Journal:  Cancers (Basel)       Date:  2020-05-22       Impact factor: 6.639

Review 10.  Are Probiotic Really Safe for Humans?

Authors:  Anna Zawistowska-Rojek; Stefan Tyski
Journal:  Pol J Microbiol       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.